According to a recent filing with the Securities and Exchange Commission, Mr. Johnson’s salary for 2014 will be $1.1 million. Mr. Rutherford will earn $600,000. The compensation committee within HCA’s board of directors approved the figures.
Most of the compensation earned by investor-owned company executives comes in the form of bonuses and stock options. For example, in 2012, Mr. Johnson earned $27.2 million in total compensation. Base salary comprised only a small portion of that total ($891,650). He also received $1.44 million in cash bonuses, $3.63 million in deferred earnings, $5.58 million in stock appreciation right awards and more than $15.7 million in other vested stock options.
Mr. Johnson officially took over for Richard Bracken this year, and Mr. Rutherford replaced Mr. Johnson. In 2012, Mr. Bracken recorded total compensation exceeding $46.3 million — one of the highest, single-year amounts ever doled out to a for-profit hospital executive.
More Articles on Hospital Executive Compensation:
Carolinas CEO Michael Tarwater Collects $4.9M in 2013
Former Cape Cod Healthcare CEO Got $2M After Resignation
The Great Pay Debate: 5 Hospital Executive Compensation Trends for 2014
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
